A duo of experts from Weill Cornell Medicine talked about the advancements made in diffuse midline gliomas research and clinical trials that may offer new hope for improving its historically poor prognosis.
Mark M. Souweidane, MD
Advertisement
Articles by Mark M. Souweidane, MD
Advertisement
Latest Updated Articles
A Changing Clinical Landscape: Promising Therapeutic Avenues in the Treatment of DIPG and Other Diffuse Midline GliomasPublished: March 21st 2025 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Inebilizumab for AChR- and MuSK-Positive Generalized Myasthenia Gravis
2
FDA Clears Pivotal Phase 3 PREVAiLS Study of Pridopidine in Early, Rapidly Progressive ALS
3
Beyond Dravet and LGS: Elizabeth Thiele, MD, PhD, on New Data for Epidiolex in DEEs
4
Survey identifies Fever-Related Seizure Reduction as Key Feature of CDKL5 Deficiency Disorder
5
